Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Surgical Endoscopy, 38 (11), 65606565
10.1016/j.eprac.2021.12.007 Summary Keywords drug-induced, glucagon-like peptide-1, inhibitors of dipeptidyl peptidase 4 (DPP-4), pancreatitis, sodium-glucose transport protein 2 (SGLT2) inhibitors Citation Alenzi KA, Alsuhaibani D, Batarfi B and Alshammari TM (2024) Pancreatitis with use of new diabetic medications: a real-world data study using the post-marketing FDA adverse event reporting system (FAERS) database
For instance, it may affect the metabolism of drugs that are substrates of the cytochrome P450 enzyme system, potentially altering their efficacy or toxicity
Semaglutide Outpaces Metformin in Time and Effectiveness Semaglutide users experienced significant weight loss in only three months (14.7 lbs), while metformin users required six months to achieve a smaller reduction
